CRISPR Therapeutics AG

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
CRISPR Therapeutics AG
TickerCRSP
CIK #0001674416
CUSIPH17182108
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
AddressAeschenvorstadt 36, Basel, 4051
Source [EDGAR]
CIK Filing 2011 - 2024
[0001674416] 10-K
[0001674416] 10-Q
[0001674416] 3
[0001674416] 4
[0001674416] 8-K
[0001674416] D
[0001674416] SC 13D
[0001674416] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Capital International Investors CRISPR Therapeutics AG [2023-02-13] 7.1
ARK Investment Management LLC CRISPR Therapeutics AG [2020-10-09] 12.05
Capital International Investors CRISPR Therapeutics AG [2020-09-10] 10.7
Capital International Investors CRISPR Therapeutics AG [2020-09-10] 10.7
Sumitomo Mitsui Trust Holdings Inc CRISPR Therapeutics AG [2020-02-12] 5.08
Nikko Asset Management Americas Inc CRISPR Therapeutics AG [2020-02-12] 5.08
Vertex Pharmaceuticals Inc / Ma CRISPR Therapeutics AG [2019-11-26] 0.1
Vertex Pharmaceuticals Inc / Ma CRISPR Therapeutics AG [2018-12-21] 10.1
Vertex Pharmaceuticals Inc / Ma CRISPR Therapeutics AG [2017-02-13] 8.0
New Enterprise Associates 15 LP CRISPR Therapeutics AG [2017-02-06] 8.1
Versant Venture Capital IV LP CRISPR Therapeutics AG [2016-11-03] 11.0
Abingworth LLP CRISPR Therapeutics AG [2016-11-03] 6.6
Celgene Corp /DE/ CRISPR Therapeutics AG [2016-10-31] 12.3
Bayer Global Investments BV CRISPR Therapeutics AG [2016-10-28] 12.8
GlaxoSmithKline PLC CRISPR Therapeutics AG [2016-10-28] 8.3
Form 3/4/5 Filer 2011 - 2024
Fardis Maria
CRISPR Therapeutics AG
George Simeon
Behbahani Ali
Treco Douglas A
High Katherine A
Greene John
Fleming Harold Edward
Kulkarni Samarth
Morrow Phuong Khanh
Prasad Raju
Kasinger James R
Smith Brendan
Klein Lawrence Otto
Bolzon Bradley J PhD
Ho Tony W
Tomsicek Michael John
Novak Rodger
Cagnoni Pablo J
Vertex Pharmaceuticals Inc / Ma
Vertex Pharmaceuticals (Europe) Ltd
Emster Kurt von
Woiwode Thomas
Versant Venture Capital V (Canada), LP
Versant Ophthalmic Affiliates I, L.P.
Versant Venture Capital V, L.P.
Versant Ventures V, LLC
Versant Affiliates Fund V, L.P.
Versant Ventures IV, LLC
Versant Side Fund IV, L.P.
Versant Venture Capital IV, L.P.
Bayer Aktiengesellschaft
Bayer Global Investments B.V.
Dylan-Hyde Tyler
Celgene Corp /DE/
Versant Ventures V (Canada), L.P.
Subramanian Kala
Coles N Anthony
Lundberg Sven Ante
GSK PLC
Hadley Harbor Master Investors (Cayman) L.P.
Form 13F Holdings
Firm Period DFND Voting Shares
ARK Investment Management LLC [2023-03-31] SOLE 7,304,293.0 7,990,188.0
Capital International Investors [2023-03-31] DFND 6,023,638.0 6,023,638.0
Sumitomo Mitsui Trust Holdings, Inc. [2023-03-31] DFND 3,973,180.0 3,973,180.0
Nikko Asset Management Americas Inc [2023-03-31] SOLE 3,604,564.0 3,972,139.0
T. Rowe Price Investment Management, Inc. [2023-03-31] SOLE 1,448,282.0 3,664,371.0
BlackRock Inc. [2023-03-31] SOLE 2,669,721.0 2,798,581.0
FMR LLC [2023-03-31] DFND 2,136,757.0 2,139,056.0
State Street Corp [2023-03-31] DFND 1,896,138.0 1,986,187.0
NEA Management Company LLC [2023-03-31] DFND 1,587,854.0 1,587,854.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 1,392,430.0
Loomis Sayles & Co L P [2023-03-31] DFND 1,052,895.0 1,156,810.0
Price T Rowe Associates Inc /MD/ [2023-03-31] SOLE 223,949.0 1,081,903.0
Bellevue Group AG [2023-03-31] DFND 899,800.0 899,800.0
Credit Suisse AG [2023-03-31] DFND 827,208.0 847,273.0
Armistice Capital LLC [2023-03-31] SOLE 824,000.0 824,000.0
Geode Capital Management LLC [2023-03-31] DFND 809,984.0 809,984.0
Susquehanna International Group LLP [2023-03-31] DFND 296,789.0 759,789.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 640,777.0 640,777.0
Citadel Advisors LLC [2023-03-31] DFND 621,239.0 621,239.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 585,508.0 594,682.0
JPMorgan Chase & Co [2023-03-31] DFND 480,551.0 575,953.0
Bank of America Corp /DE/ [2023-03-31] DFND 16,525.0 517,706.0
Federated Hermes Inc [2023-03-31] DFND 508,758.0 508,758.0
Versant Venture Management LLC [2023-03-31] OTR 0.0 498,558.0
Renaissance Technologies LLC [2023-03-31] SOLE 0.0 495,103.0
Morgan Stanley [2023-03-31] DFND 214,028.0 470,526.0
Barclays PLC [2023-03-31] SOLE 461,759.0 461,759.0
Walleye Trading LLC [2023-03-31] SOLE 450,300.0 450,300.0
Goldman Sachs Group Inc [2023-03-31] DFND 293,853.0 308,454.0
Allspring Global Investments Holdings, LLC [2023-03-31] DFND 147,558.0 303,779.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com